Efficacy of Vitamin D3 Derivatives in the Treatment of Psoriasis Vulgaris: A Preliminary Report
- 1 September 1993
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 68 (9) , 835-841
- https://doi.org/10.1016/s0025-6196(12)60690-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgarisThe Lancet, 1991
- Vitamin D3 and psoriasis: A randomized double-blind placebo-controlled studyJournal of Dermatological Treatment, 1990
- Will 1,25-Dihydroxyvitamin D3, MC 903, and Their Analogues Herald a New Pharmacologic Era for the Treatment of Psoriasis?Archives of Dermatology, 1989
- Treatment of Psoriasis by the Topical Application of the Novel Cholecalciferol Analogue Calcipotriol (MC 903)Archives of Dermatology, 1989
- A double-blind, placebo-controlled trial of topical 1,25-dihydroxycholecalciferol in psoriasisBritish Journal of Dermatology, 1989
- A double-blind study of topical 1α,25-dihydroxyvitamin D3 in psoriasisBritish Journal of Dermatology, 1989
- Psoriasis and Vitamin D3Archives of Dermatology, 1989
- Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind studyBritish Journal of Dermatology, 1988
- Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivoBiochemical Pharmacology, 1988
- Skin as the Site of Vitamin D Synthesis and Target Tissue for 1,25-Dihydroxyvitamin D3Archives of Dermatology, 1987